National Development and Reform Commission: 10 drugs with more price consultation and report in June

Source: the national development and Reform Commission issued a notice on May 22, 2016, July 18, 2016, deploying to carry out special inspection on drug prices nationwide, regulating the market order of drug prices, and reporting cases involving drug prices became the focus of supervision On July 14, the official website of the national development and Reform Commission released the analysis report of 12358 price supervision platform in June The report points out that since the implementation of the drug price reform, the market price has been generally stable From January to June, 12358 price supervision platform accepted 6098 drug price consultation and reports The problems most reflected by consumers are: 1 The purchase price of physical drugstores is significantly higher than that of online shopping; 2 The sales price of physical drugstores is not strictly implemented; 3 The price of hospital drugstores is significantly higher than that of other drugstores outside the hospital when selling the same kind of drugs; 4 The price of individual drugs increases significantly; 5 The monopoly of API by individual enterprises According to the report, in the next stage, we will carry out in-depth medical and other special inspections Pay close attention to the complaints and Reflections on drug price issues on 12358 price supervision platform, timely correct and seriously investigate and deal with them in combination with special inspection and deployment, and increase the exposure of illegal cases At the same time of investigating and handling cases, the paper analyzes and studies the boundary of price behavior in combination with the characteristics of the industry, and timely rises to the universal behavior rules, so as to realize the effective guidance of market price behavior.